Saturday, June 20, 2026

Kim Jong Un Tours New 5,000-Ton Destroyer as U.S.-South Korea Drills Begin

Kim Jong Un inspects a new destroyer, emphasizing nuclear capabilities amid U.S.-South Korea military drills, while avoiding provocations.

Remembering Lee Sun Kyun: Actor’s Legacy One Year After His Passing

South Korean actor Lee Sun Kyun is remembered on the anniversary of his passing, following a successful career in film and television.

Apple Supplier Foxconn Replaces Workers with Smart Robots

Foxconn is revolutionizing assembly lines with AI and robotics, potentially reducing the need for low-wage labor.

Tag: Nesuparib

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

Nesuparib: The Game-Changing Cancer Treatment for Small Cell Lung Cancer Revealed at AACR 2026

Onconic Therapeutics reveals Nesuparib's promising preclinical results for small cell lung cancer, outperforming existing treatments significantly.

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.